netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.05.01  Expand sub section  Vasodilator antihypertensive drugs
Hydralazine
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Tablets
Injection

Oral hydralazine may be used in combination with long-acting nitrates in patients with heart failure who are still symptomatic despite optimal therapy with ACE inhibitor and beta blocker or when ACE inhibitors and ARBs are contra-indicated or not tolerated.

Not to be used as monotherapy (causes tachycardia and fluid retention). (BNF)

 
Link  Adult Loading Doses Policy
   
Iloprost
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
Injection

unlicensedunlicensed

For use in rheumatology patients, see attached guidelines. 
Link  Guideline for the use of intravenous iloprost in rheumatology patients
   
Sildenafil
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Red
Tablets (Revatio)
Suspension (paediatric use) unlicensedunlicensed

Formulary for treatment of pulmonary arterial hypertension.

For erectile dysfunction, see chapter 7.4.5.
 
   
Sodium Nitroprusside
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary Intravenous infusion

unlicensedunlicensed 
   
 ....
 Non Formulary Items
Ambrisentan

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Red
 
Bosentan  (Tracleer)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Red
 
Diazoxide  (Eudemine)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary Injection (discontinued)
Tablets - see section 6.1.4



 
Iloprost nebules  (Vantavis)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Minioxidil  (Loniten®)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Minoxidil

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Sitaxentan Sodium  (Thelin)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tadalafil  (Adcirca)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Tolazoline

View adult BNF View SPC online View childrens BNF
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Amber

Drugs designated amber are suitable for shared care arrangements under a shared care protocol. Prescribing may be transferred from secondary to primary care once the patient is stabilised and agreed shared care arrangements have been established. Alternatively primary care may initiate under the supervision of secondary care if this option is given in the shared care document. It is recommended that shared care arrangements should be drawn up following local discussion and agreement by prescribing parties.   

Black

These products have been reviewed by the GM Joint Formulary Group and have been deemed not suitable for prescribing for adults in primary or secondary care within Greater Manchester. These decisions have been made on the basis of safety, efficacy and cost-effectiveness of the products.  

Green

Not used   

Green 1

Drugs designated green1 are suitable for initiation and ongoing prescribing within primary care.   

Green 2

Drugs designated green2 can be initiated by primary care following written or verbal advice from a specialist and then be subsequently safely prescribed in primary care with little or no monitoring required.  

Green 3

Drugs designated green3 are suitable for on-going prescribing within primary care after specialist initiation and an initial review (unless specified) in secondary care. Little or no monitoring is required.  

Grey

Not suitable for routine prescribing but may be suitable for a defined patient population. Whilst prescribers should think very carefully before prescribing or recommending any of the products on the grey list, there may be exceptional instances when the use of one of these products is necessary for a particular patient.   

Red

Drugs designated red are considered to be specialist medicines and prescribing responsibility for these medicines should normally remain with the consultant or specialist clinician. These drugs should not be initiated or prescribed in primary care. It is recommended that the supply of these specialist medicines should be organised via the hospital pharmacy, this may include arranging for supply via a home care company.   

netFormulary